J&J's Marketing Of Risperdal For Children Slammed In Trial
Trial in a third case over abnormal breast growth allegedly caused by a Johnson & Johnson unit's antipsychotic drug got underway on Thursday as a Philadelphia jury heard arguments that the...To view the full article, register now.
Already a subscriber? Click here to view full article